Dr. Kurt Weingand trained in veterinary medicine and surgery at the University of Missouri and received his D.V.M degree in 1980.  He worked in a companion animal veterinary clinic for a year then enrolled as a National Cancer Institute trainee in the graduate program at Colorado State University and obtained a Ph.D. degree in Pathology in 1984.  

 

Dr. Weingand’s first academic appointment was at the Wake Forest University School of Medicine where he led research on mechanisms of coronary artery atherosclerosis.  Dr. Weingand became a Diplomate of the American College of Veterinary Pathology by earning board certification as a veterinary clinical pathologist in 1985.  He then became an Assistant Professor of Laboratory Medicine at Kansas State University’s College of Veterinary Medicine leading research on body fat distribution as a risk factor for coronary artery disease and providing clinical pathology instruction and service in the veterinary teaching hospital.  

 

Dr. Weingand joined Procter & Gamble (P&G) in 1988 to lead toxicologic pathology research in support of pre-clinical safety assessments.  In this role, he led an international task force that developed harmonized guidelines for clinical pathology testing in pre-clinical toxicity and safety studies.

 

Dr. Weingand transferred to P&G Health Care in 1993 as a clinical scientist to lead the conduct of human clinical trials on a variety of health care products (Metamucil, Pepto-Bismol, NyQuil, Vicks).  In 1997, he led product development of a new non-drug topical analgesic product that culminated in the launch of ThermaCare HeatWraps in 2000.  

 

In 2001, Dr. Weingand began his leadership role in the P&G Health Sciences Institute to lead technical outreach of new research information and serve as the external spokesperson for OTC Health Care brands.  He advanced to Associate Director of Global External Relations where he led commercial innovation for the launch of Prilosec OTC in 2004.  In 2006, he was appointed to lead P&G Pet Care’s alternative animal models development program and site operations in research & development at the Lewisburg Innovation Center.  

 

Dr. Weingand accepted responsibility for P&G Pet Care’s Global External Relations organization in 2007 to lead Scientific Communications, Professional Relations, Public Relations, Consumer Relations, Corporate Reputation, Government Relations, and Crisis Management for the Iams and Eukanuba brands.  He led the P&G Pet Care global crisis team during the 2007 Menu Foods pet food recall.

 

Dr. Weingand is currently the President of SciComPro-LLC™, a privately held life sciences consulting firm.  He is the host and co-producer of Health Today, a weekly talk radio program on 55KRC in Cincinnati, Ohio.  Dr. Weingand is a Principal Investigator in clinical trials of medical devices for Wyeth Consumer Heatlhcare and also works as a clinical pathologist at Veterinary Pathology Services, Inc. in Mason. OH.

 

 

SciComPro-LLC™ has strategic alliances with select businesses to offer the world-class services with high quality and maximum value.

 

 

 

President & Founder of Davidson Communications & External Relations, LLC, Ria Davidson has 20 years of experience in communications, public relations, promotion, issues management, crisis planning and response, and rumor control and avoidance. She has worked with clients in virtually all industries and market segments. She offers clients high level strategic thinking and the ability to communicate, particularly sensitive and technical information, in a way that generates interest and understanding.